Literature DB >> 20590578

A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells.

Lesley A Ford1, Anke J Roelofs, Sharon Anavi-Goffer, Luisa Mowat, Daniel G Simpson, Andrew J Irving, Michael J Rogers, Ann M Rajnicek, Ruth A Ross.   

Abstract

BACKGROUND AND
PURPOSE: Increased circulating levels of L-alpha-lysophosphatidylinositol (LPI) are associated with cancer and LPI is a potent, ligand for the G-protein-coupled receptor GPR55. Here we have assessed the modulation of breast cancer cell migration, orientation and polarization by LPI and GPR55. EXPERIMENTAL APPROACH: Quantitative RT-PCR was used to measure GPR55 expression in breast cancer cell lines. Cell migration and invasion were measured using a Boyden chamber chemotaxis assay and Cultrex invasion assay, respectively. Cell polarization and orientation in response to the microenvironment were measured using slides containing nanometric grooves. KEY
RESULTS: GPR55 expression was detected in the highly metastatic MDA-MB-231 breast cancer cell line. In these cells, LPI stimulated binding of [(35)S]GTPgammaS to cell membranes (pEC(50) 6.47 +/- 0.45) and significantly enhanced cell chemotaxis towards serum. MCF-7 cells expressed low levels of GPR55 and did not migrate or invade towards serum factors. When GPR55 was over-expressed in MCF-7 cells, serum induced a robust migratory and invasive response, which was further enhanced by LPI and prevented by siRNA to GPR55. The physical microenvironment has been identified as a key factor in determining breast tumour cell metastatic fate. LPI endowed MDA-MB-231 cells with the capacity to detect shallow (40 nm deep) grooved slides and induced marked cancer cell polarization on both flat and grooved surfaces. CONCLUSIONS AND IMPLICATIONS: LPI and GPR55 play a role in the modulation of migration, orientation and polarization of breast cancer cells in response to the tumour microenvironment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590578      PMCID: PMC2931574          DOI: 10.1111/j.1476-5381.2010.00743.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Nucleus alignment and cell signaling in fibroblasts: response to a micro-grooved topography.

Authors:  Matthew J Dalby; Mathis O Riehle; Stephen J Yarwood; Chris D W Wilkinson; Adam S G Curtis
Journal:  Exp Cell Res       Date:  2003-04-01       Impact factor: 3.905

2.  The effect of topographic characteristics on cell migration velocity.

Authors:  Jean-Pierre Kaiser; Andreas Reinmann; Arie Bruinink
Journal:  Biomaterials       Date:  2006-06-30       Impact factor: 12.479

3.  Helix 8 Leu in the CB1 cannabinoid receptor contributes to selective signal transduction mechanisms.

Authors:  Sharon Anavi-Goffer; Daniel Fleischer; Dow P Hurst; Diane L Lynch; Judy Barnett-Norris; Shanping Shi; Deborah L Lewis; Somnath Mukhopadhyay; Allyn C Howlett; Patricia H Reggio; Mary E Abood
Journal:  J Biol Chem       Date:  2007-06-26       Impact factor: 5.157

Review 4.  Biologic functions of the G12 subfamily of heterotrimeric g proteins: growth, migration, and metastasis.

Authors:  Patrick Kelly; Patrick J Casey; Thomas E Meigs
Journal:  Biochemistry       Date:  2007-05-16       Impact factor: 3.162

5.  Spontaneous migration of cancer cells under conditions of mechanical confinement.

Authors:  Daniel Irimia; Mehmet Toner
Journal:  Integr Biol (Camb)       Date:  2009-07-16       Impact factor: 2.192

6.  Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses.

Authors:  Y Xiao; Y Chen; A W Kennedy; J Belinson; Y Xu
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

7.  Identification of GPR55 as a lysophosphatidylinositol receptor.

Authors:  Saori Oka; Keisuke Nakajima; Atsushi Yamashita; Seishi Kishimoto; Takayuki Sugiura
Journal:  Biochem Biophys Res Commun       Date:  2007-08-24       Impact factor: 3.575

8.  Lysophospholipids are potential biomarkers of ovarian cancer.

Authors:  Rebecca Sutphen; Yan Xu; George D Wilbanks; James Fiorica; Edward C Grendys; James P LaPolla; Hector Arango; Mitchell S Hoffman; Martin Martino; Katie Wakeley; David Griffin; Rafael W Blanco; Alan B Cantor; Yi-jin Xiao; Jeffrey P Krischer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-07       Impact factor: 4.254

9.  Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK.

Authors:  Martina Stähle; Christine Veit; Ulla Bachfischer; Karina Schierling; Bettina Skripczynski; Alan Hall; Peter Gierschik; Klaudia Giehl
Journal:  J Cell Sci       Date:  2003-08-05       Impact factor: 5.285

10.  Contact guidance of CNS neurites on grooved quartz: influence of groove dimensions, neuronal age and cell type.

Authors:  A Rajnicek; S Britland; C McCaig
Journal:  J Cell Sci       Date:  1997-12       Impact factor: 5.285

View more
  69 in total

1.  Lysophosphatidylinositol stimulates [³⁵S]GTPγS binding in the rat prefrontal cortex and hippocampus.

Authors:  Maria Luisa Rojo; Antonio Rodriguez-Gaztelumendi; Christopher J Fowler
Journal:  Neurochem Res       Date:  2012-01-22       Impact factor: 3.996

2.  Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-ones.

Authors:  Maria Elena Meza-Aviña; Mary A Lingerfelt; Linda M Console-Bram; Thomas F Gamage; Haleli Sharir; Kristen E Gettys; Dow P Hurst; Evangelia Kotsikorou; Derek M Shore; Marc G Caron; Narasinga Rao; Larry S Barak; Mary E Abood; Patricia H Reggio; Mitchell P Croatt
Journal:  Bioorg Med Chem Lett       Date:  2016-02-16       Impact factor: 2.823

3.  The LPI/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling.

Authors:  Xiao-Lei Zhou; Xin Guo; Yu-Pin Song; Chong-Yue Zhu; Wei Zou
Journal:  Acta Pharmacol Sin       Date:  2017-11-30       Impact factor: 6.150

4.  Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.

Authors:  Evangelia Kotsikorou; Karla E Madrigal; Dow P Hurst; Haleli Sharir; Diane L Lynch; Susanne Heynen-Genel; Loribelle B Milan; Thomas D Y Chung; Herbert H Seltzman; Yushi Bai; Marc G Caron; Larry Barak; Mary E Abood; Patricia H Reggio
Journal:  Biochemistry       Date:  2011-06-01       Impact factor: 3.162

5.  Concurrent activation of β2-adrenergic receptor and blockage of GPR55 disrupts pro-oncogenic signaling in glioma cells.

Authors:  Artur Wnorowski; Justyna Such; Rajib K Paul; Robert P Wersto; Fred E Indig; Krzysztof Jozwiak; Michel Bernier; Irving W Wainer
Journal:  Cell Signal       Date:  2017-05-08       Impact factor: 4.315

6.  GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine.

Authors:  R Ferro; A Adamska; R Lattanzio; I Mavrommati; C E Edling; S A Arifin; C A Fyffe; G Sala; L Sacchetto; G Chiorino; V De Laurenzi; M Piantelli; O J Sansom; T Maffucci; M Falasca
Journal:  Oncogene       Date:  2018-07-30       Impact factor: 9.867

7.  (R,R')-4'-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motility.

Authors:  Rajib K Paul; Artur Wnorowski; Isabel Gonzalez-Mariscal; Surendra K Nayak; Karolina Pajak; Ruin Moaddel; Fred E Indig; Michel Bernier; Irving W Wainer
Journal:  Biochem Pharmacol       Date:  2013-12-16       Impact factor: 5.858

8.  THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner.

Authors:  Marc Richard Kolbe; Tim Hohmann; Urszula Hohmann; Chalid Ghadban; Ken Mackie; Christin Zöller; Julian Prell; Jörg Illert; Christian Strauss; Faramarz Dehghani
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.639

9.  Cannabinoids as anticancer therapeutic agents.

Authors:  Olga Kovalchuk; Igor Kovalchuk
Journal:  Cell Cycle       Date:  2020-04-05       Impact factor: 4.534

10.  Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture.

Authors:  Liting Deng; Lindsay Ng; Tatsuya Ozawa; Nephi Stella
Journal:  J Pharmacol Exp Ther       Date:  2016-11-07       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.